Skip to main content

Table 5 Lens vascular endothelial growth factor (VEGF) and caspase-12 in control and experimental groups

From: Potential prophylactic effect of chemical chaperones for alleviation of endoplasmic reticulum stress in experimental diabetic cataract

Groups

VEGF (pg/mg protein)

Caspase-12 (ng/mg protein)

Group 1: Control

 Range

0.38–1.6

0.07–0.21

 Mean ± S.D

0.87 ± 0.55

0.15 ± 0.06

Group 2: diabetic model

 Range

1.9–3.4

0.3–0.81

 Mean ± S.D

2.81 ± 0.64a

0.53 ± 0.19 a

Group 3: diabetic model + 4PBA

 Range

0.5–2.7

0.07–0.23

 Mean ± S.D

1.3 ± 0.87 b

0.12 ± 0.06 b

Group 4: diabetic model + TUDCA

 Range

1.25–2

0.19–0.36

 Mean ± S.D

1.73 ± 0.27a,b

0.26 ± 0.08 b

Group 5: diabetic model + TMAO

 Range

1–3

0.25–0.75

 Mean ± S.D

2 ± 0.95a

0.41 ± 0.17a

  1. SD standard deviation n = 15
  2. aSignificant in comparing with control group at P < 0.05
  3. bSignificant in comparing with diabetic model group at P < 0.05